REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $634,385 | -39.7% | 38,541 | -26.8% | 0.00% | – |
| Q2 2023 | $1,052,713 | -25.2% | 52,662 | -29.2% | 0.00% | – |
| Q1 2023 | $1,406,923 | +309.4% | 74,401 | +391.1% | 0.00% | – |
| Q4 2022 | $343,625 | -83.5% | 15,151 | -80.7% | 0.00% | – |
| Q3 2022 | $2,078,000 | +221.2% | 78,613 | +200.0% | 0.00% | – |
| Q2 2022 | $647,000 | -82.8% | 26,200 | -76.9% | 0.00% | – |
| Q1 2022 | $3,767,000 | -59.9% | 113,482 | -60.5% | 0.00% | – |
| Q4 2021 | $9,392,000 | +40.0% | 287,214 | +79.5% | 0.00% | -100.0% |
| Q3 2021 | $6,707,000 | +281.5% | 159,998 | +253.4% | 0.00% | – |
| Q2 2021 | $1,758,000 | -44.6% | 45,272 | -51.3% | 0.00% | – |
| Q1 2021 | $3,173,000 | -77.8% | 93,044 | -70.5% | 0.00% | -100.0% |
| Q4 2020 | $14,322,000 | +710.1% | 315,774 | +391.6% | 0.00% | – |
| Q3 2020 | $1,768,000 | -77.7% | 64,229 | -70.1% | 0.00% | -100.0% |
| Q2 2020 | $7,912,000 | -7.6% | 214,828 | -18.8% | 0.00% | 0.0% |
| Q1 2020 | $8,562,000 | -23.2% | 264,430 | -2.8% | 0.00% | -50.0% |
| Q4 2019 | $11,144,000 | -5.0% | 271,994 | -17.4% | 0.00% | 0.0% |
| Q3 2019 | $11,728,000 | -70.7% | 329,439 | -57.8% | 0.00% | -20.0% |
| Q2 2019 | $40,066,000 | +143.7% | 779,934 | +171.9% | 0.01% | -28.6% |
| Q1 2019 | $16,441,000 | +69.5% | 286,876 | +24.1% | 0.01% | +133.3% |
| Q4 2018 | $9,700,000 | -31.9% | 231,226 | +22.5% | 0.00% | -40.0% |
| Q3 2018 | $14,254,000 | -5.4% | 188,800 | -10.1% | 0.01% | 0.0% |
| Q2 2018 | $15,075,000 | +347.5% | 210,100 | +86.1% | 0.01% | +400.0% |
| Q1 2018 | $3,369,000 | -65.5% | 112,885 | -61.6% | 0.00% | -66.7% |
| Q4 2017 | $9,763,000 | +981.2% | 293,622 | +971.6% | 0.00% | – |
| Q3 2017 | $903,000 | +8.5% | 27,400 | -38.9% | 0.00% | – |
| Q4 2016 | $832,000 | +740.4% | 44,834 | +261.4% | 0.00% | – |
| Q2 2016 | $99,000 | – | 12,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |